Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

ATR-IN-8

ATR-IN-8 is a potent inhibitor of ATR. ATR is a key enzyme in the homologous recombination repair pathway and belongs to the PIKK family. ATR-IN-8 has the potential for the research of cancer diseases (extracted from patent WO2021143821A1, compound 3) [1].

Product Specifications

CAS Number

[2672511-20-3]

UNSPSC

12352005

Target

ATM/ATR

Type

Reference compound

Related Pathways

Cell Cycle/DNA Damage; PI3K/Akt/mTOR

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/atr-in-8.html

Solubility

10 mM in DMSO

Smiles

N=S1(C2(CC2)C3=NC(C4=C5C(NC=C5)=NC=C4)=NC(N6[C@@H](COCC6)C)=C3C1)=O

Molecular Formula

C20H22N6O2S

Molecular Weight

410.49

References & Citations

[1]Li Xin, et al. Thickened heteroaryl derivatives, their preparation methods and their application in medicine. Patent WO2021143821A1.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Boldenone Undecylenate 100mg
A15028-100 100 mg

Boldenone Undecylenate 100mg

Ask
View Details
Mouse Dynactin subunit 1, Dctn1 ELISA KIT
ELI-26333m 96 Tests

Mouse Dynactin subunit 1, Dctn1 ELISA KIT

Ask
View Details
Rabbit Anti-FADD Polyclonal Antibody
PAV7158 100 μL

Rabbit Anti-FADD Polyclonal Antibody

Ask
View Details
C2orf88 Recombinant Protein Antigen
NBP2-14407PEP 0.1 mL

C2orf88 Recombinant Protein Antigen

Ask
View Details
TULP4 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
48844111 3x 1.0 µg

TULP4 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)

Ask
View Details
Lentiviral human CCDC85A shRNA (UAS) - Lentiviral human CCDC85A shRNA (UAS, GFP) (100)
GTR15096237 1 Vial

Lentiviral human CCDC85A shRNA (UAS) - Lentiviral human CCDC85A shRNA (UAS, GFP) (100)

Ask
View Details